Revon Media
  • Newspaper
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Live Edition
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Media
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • About Us
  • Contact Us
No Result
View All Result
  • Newspaper
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Live Edition
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Media
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • About Us
  • Contact Us
No Result
View All Result
Revon Media
No Result
View All Result

PPIM wants Ivermectin approval

PPIM wants Ivermectin approval
Share on FacebookShare on Twitter

NGO also lodges police report against MoH for not using Ivermectin to treat Covid-19 patients

BY FATIHAH MANAF

The Malaysia Muslim Consumers Association (PPIM) is hopeful that Malaysia will approve the use of Ivermectin in treating Covid-19 patients.

Its President Dato’ Nadzim Johan told The Health: “We hope that Ivermectin will be allowed in Malaysia for those who want it.

“We’re not making this an issue. Just like vaccines, we should not force people to take it.”

Dato’ Nadzim Johan

PPIM was one of the NGOs that signed a letter calling for the approval of Ivermectin as Plan B for vaccination.

In February, the letter, also signed by several associations and individuals, urged the government to approve the use of Ivermectin to treat Covid-19 patients in Malaysia.

The letter shared the benefits of Ivermectin as a low-cost medicine that outweighed its adverse side effects. The letter stated that many countries had used Ivermectin to treat diseases many years ago. However, in Malaysia, the usage was only limited to treatment for animals.

According to the letter, Ivermectin, an anti-parasitic and antiviral drug, was developed by Japan in 1975. More than 3.7 billion doses were distributed globally and used by millions of people in the last 30 years or so, with no reported adverse side effects or deaths.

The letter also addressed the need for ‘Plan B’ by the government given the worsening Covid-19 situation in the country. It said the approval for Ivermectin is a safe, cheap and effective ‘weapon’ against Covid-19 should be
done quickly.

It also pointed out that the Ministry of Health (MoH) had given conditional approval to the controversial Pfizer experimental mRNA vaccine without any clinical trials in Malaysia.

The letter received a mixed response from the public. Some were hopeful to have an affordable and effective alternative treatment for Covid-19, but many were sceptical.

Police report lodged

PPIM also upped the ante on June 23 by lodging a police report against the MoH for refusing to use Ivermectin to prevent the spread of Covid-19.

Nadzim said the ministry’s refusal to consider Ivermectin was a criminal offence as more than 2,300 Covid-19 patients had died in Malaysia.

“Numerous clinical trials have proven that Ivermectin can reduce the risk of infection at 88 per cent. It can also reduce the fatality rate at 83 per cent, and many prophylaxes have also confirmed it can reduce Covid-19 transmissions.

“Covid-19 deaths are increasing every day, and we should be open and accept the views of others as long as it is proven effective to prevent the spread of Covid-19,” he said.

Science the best weapon

The MoH has yet to approve Ivermectin following the lack of studies and clinical evidence.

On May 16, the Director-General of Health Malaysia, Datuk Dr Noor Hisham Abdullah, in his blog, stated: “Regulatory bodies including the US FDA and the European EMA, after evaluating these studies, concluded there was insufficient evidence to support Ivermectin as treatment of Covid-19.

“The WHO also issued guidelines against Ivermectin in the treatment of Covid-19 except in clinical trial settings.”

In his post, Dr Noor Hisham doubted the use of Ivermectin in Covid-19 treatment. He said the MoH could not endorse Ivermectin to prevent or treat the illness without the benefit of evidence from well-designed clinical trials.

Dr Noor Hisham emphasised it was important for MoH to figure out what really worked and hoped this study would correct MOH’s perspective on the clinical effectiveness of Ivermectin. He argued that science should remain the best weapon against the SARS-Cov-2 virus, not circumstantial hype.

“Personally, we can see Ivermectin has been used worldwide, such as in India but is still not allowed in Malaysia. If it is clinically proven to bring more benefits later, then those who want to consume should be allowed to do so,” said Nadzim.

PPIM is an active NGO that strives to change the landscape of consumerism among Muslims in Malaysia. — The Health

Tags: Covid-19IvermectinThe Health June/JulytheHealth
Previous Post

MoH starts Ivermectin trial

Next Post

The price of research collaboration

Live Edition Paper

NOV 2020 ePaper

OCT 2020 ePaper


 

Subscribe for free complimentary live editions:

Recent News

  • Overlooked toolbox in Covid-19 management
    October 6, 2021
    There is the possibility of long-range virus transmission in poorly ventilated […]
  • Vaccinating the undocumented and refugees
    October 14, 2021
    Despite the language barrier and incomplete documents, Medilink has overcome […]
  • An award-winning invention
    November 29, 2021
    From concept to shelf, the rambutan rind has been developed by SIRIM into a […]
  • A platform for professional service
    December 21, 2022
    Optometrists want to be a means where the public can refer to and obtain […]
  • The pandemic and adolescent emotional health
    April 28, 2022
    It is worrying depression and anxiety symptoms during Covid-19 have doubled, […]

Connect

Office

Revon Media Sdn Bhd
A member of Revongen Corporation
Headquarters
Revongen Corporation Center,
Level 17, Top Glove Tower, No.16,
Persiaran Setia Dagang,Setia Alam,
Seksyen U13, 40170 Shah Alam,
Selangor Darul Ehsan, Malaysia.

Contact

Tel: +603 3359 1166
Fax: +6 03 3358 0303

Copyright © 2021 Revon Media Sdn Bhd. A publication of Revon Media Sdn Bhd. About Us | Contact Us | Privacy Policy | Terms of use

No Result
View All Result
  • Newspaper
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Live Edition
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Media
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • About Us
  • Contact Us

© 2021 Revon Media Sdn Bhd. A publication of Revon Media Sdn Bhd

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist